St George's Gynaecological Oncology Website
Download Microsoft Word Version For Printing
Gynaecological Oncology Services
by
Thomas Ind
Consultant Gynaecological Surgeon
St George's & Royal Marsden Hospitals
Introduction
Gynaecological Oncology services in the UK are provided by primary health care teams, Cancer Units, Cancer Centres, and other health care providers. To fully understand how a patient's pathway is organised it is important to understand the cancer network and the professionals that work within each aspect of the network.
Primary Health Care Teams
Most patients present to their general practitioner. However, they may be seen by the practice nurse or another health care professional. For example, most smear tests are now performed by nurses.
When a general practitioner or a member of the primary health care team queries a possible gynaecological cancer the patient is referred to the local gynaecological cancer unit for assessment. This referral is normally done through the 'Two Week Rule' where the referral letter is faxed to the hospital which has an obligation to see the patient with two weeks of referral. A more recent method is by direct booking into consultants clinics via a computer network.
The department of health have issued guidelines as to what cases should be seen urgently. These are detailed below.
Urgent referrals (see within two weeks)
Lesion suspicious of cancer on cervix or vagina on speculum examination.
Lesion suspicious of cancer on clinical examination of the vulva.
Palpable pelvic mass not obviously fibroids.
Suspicious pelvic mass on pelvic ultrasound.
More than one or a single heavy episode of postmenopausal bleeding (PMB) in women aged > 55 years who are not on HRT.
Postcoital bleeding (PCB) age > 35 years that persists for more than four weeks.
HRT: unexpected or prolonged bleeding persisting for more than 4 weeks after stopping HRT.
Early referral
Indications for 'early' referral (i.e. within 4 - 6 weeks) but not 'urgent' referral.
Any other woman with postmenopausal bleeding not on HRT.
Repeated unexplained postcoital bleeding.
NB In women over 45 years with persistent abdominal pain or distension, ovarian cancer should be considered and a pelvic examination performed.
The Cancer Unit
The cancer unit normally sees patients and makes the diagnosis. About 1 in 10 women referred to a hospital through the two week rule will actually have cancer. Some will have precancerous conditions such as atypical endometrial hyperplasia. The cancer unit will treat some of the cancers diagnosed and organise continuing care for those who do not have cancer if required.
In each cancer unit there is a lead clinician responsible for these patients. He/she liaises with the primary health care teams and the cancer centre. The cancer unit lead will normally have a colleague who assists during annual leave and a specialist nurse who also assists. There is a core team that usually meets at least fortnightly to discuss cases and consists of the gynaecologist, the nurse, radiologists, and pathologists.
The Cancer Centre
The cancer centre manages most (but not all) gynaecological cancers. The national guidelines recommend the following patients should be managed in the gynaecological cancer centre.
The cancer centre's team consists of a variety of people who work in a multidisciplinary group. The core team consists of the following;
Gynaecological Oncology Surgeons
Medical Oncologists
Clinical Oncologists
Palliative care physicians
Clinical Nurse Specialists
Histopathologists
Radiologists
The extended team consists of
Urological surgeons
Colorectal surgeons
Plastic surgeons
Vascular surgeons
Stoma therapists
Counsellors
Physiotherapists
And others
In the cancer centre, the multidisciplinary team meets weekly and discusses every new patient.
The MDT
The MDT (Multidisciplinary Team Meeting) occurs weekly in the cancer centre. At this meeting all new cases are discussed. The aim of the meeting is to ensure that each patient is channelled through the correct speciality for their treatment (e.g. radiotherapy, chemotherapy, or surgery). Other aspects of care such as psychosocial support are also discussed.
Patients who should be referred to the gynaecological cancer centre
Cervix cancers
All histologically proven cases except those with stage 1a tumors
Vulval cancers
All histologically proven cases
Vaginal cancers
All histologically proven cases
Endometrial cancers
Histologically proven cases which are Grade 3 or those thought to have myometrial invasion
Uterine sarcomas
All histologically proven cases
Ovarian cysts
Those thought to be malignant
(At St George's we use the risk of malignancy index - see tutorial on ovarian cysts)